Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.

Chinese medical journal - 5 Sept 2015

Wang Bian-Hong, Li Yong-Hui, Yu Li

Abstract excerpt

OBJECTIVE: Intermediate-risk acute myeloid leukemia (IR-AML), which accounts for a substantial number of AML cases, is highly heterogeneous. We systematically summarize the latest research progress on the significance of gene mutations for prognostic stratification of IR-AML. DATA SOURCES: We conducted a systemic search from the PubMed database up to October, 2014 using various search terms and their combinations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 26315090
DOI: 10.4103/0366-6999.163400
PMCID: PMC4733808

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.PMID 26315090Read ↗

Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.Semantic proximity Read ↗

Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia.Semantic proximity Read ↗

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.Semantic proximity Read ↗

Next Generation Sequencing of Acute Myeloid Leukemia: Influencing PrognosisSemantic proximity Read ↗

Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapiesSemantic proximity Read ↗

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?Semantic proximity Read ↗

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic StrategiesSemantic proximity Read ↗

Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients.Semantic proximity Read ↗

Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience.Semantic proximity Read ↗

Mutations in AML: prognostic and therapeutic implications.Semantic proximity Read ↗

[Mutational Spectrum and Prognosis Analysis of AML Patients Based on High-Throughput Sequencing].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.